ArTS Archivio della ricerca di Trieste

STOCCO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.125
EU - Europa 8.620
AS - Asia 6.793
SA - Sud America 1.011
AF - Africa 283
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.912
PL - Polonia 2.590
SG - Singapore 2.506
IT - Italia 1.713
CN - Cina 1.487
VN - Vietnam 840
BR - Brasile 762
SE - Svezia 743
HK - Hong Kong 661
DE - Germania 654
FI - Finlandia 450
FR - Francia 433
UA - Ucraina 429
GB - Regno Unito 376
KR - Corea 302
RU - Federazione Russa 292
NL - Olanda 233
IN - India 204
TR - Turchia 197
IE - Irlanda 170
BG - Bulgaria 136
JP - Giappone 113
AR - Argentina 87
CA - Canada 81
MA - Marocco 81
MX - Messico 81
BD - Bangladesh 70
BE - Belgio 62
AT - Austria 60
ES - Italia 55
IQ - Iraq 54
ZA - Sudafrica 48
SN - Senegal 45
PK - Pakistan 44
SA - Arabia Saudita 43
EC - Ecuador 37
ID - Indonesia 36
PH - Filippine 31
EG - Egitto 30
AU - Australia 27
PT - Portogallo 27
TH - Thailandia 26
CL - Cile 25
VE - Venezuela 25
CO - Colombia 24
CH - Svizzera 22
CZ - Repubblica Ceca 21
PE - Perù 21
UZ - Uzbekistan 21
IR - Iran 20
LT - Lituania 20
TN - Tunisia 20
JO - Giordania 19
GR - Grecia 16
PY - Paraguay 15
RO - Romania 15
TW - Taiwan 14
AZ - Azerbaigian 13
MY - Malesia 13
SI - Slovenia 13
DK - Danimarca 12
DZ - Algeria 12
RS - Serbia 12
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
IL - Israele 10
NO - Norvegia 10
KE - Kenya 9
KW - Kuwait 9
AL - Albania 8
MD - Moldavia 8
UY - Uruguay 8
HR - Croazia 7
NP - Nepal 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
ET - Etiopia 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
BA - Bosnia-Erzegovina 5
DO - Repubblica Dominicana 5
GE - Georgia 5
GT - Guatemala 5
JM - Giamaica 5
MN - Mongolia 5
PA - Panama 5
CI - Costa d'Avorio 4
EE - Estonia 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
LU - Lussemburgo 4
LV - Lettonia 4
NG - Nigeria 4
NI - Nicaragua 4
PR - Porto Rico 4
BH - Bahrain 3
CG - Congo 3
EU - Europa 3
Totale 28.816
Salva come PNG Salva come JPEG
Città #
Warsaw 2.411
Singapore 1.452
Ashburn 1.289
Woodbridge 1.051
Fairfield 1.014
Ann Arbor 924
Chandler 800
San Jose 672
Trieste 649
Houston 633
Hong Kong 627
Wilmington 500
Seattle 442
Jacksonville 380
Cambridge 341
Beijing 329
Munich 294
Seoul 279
Ho Chi Minh City 276
Hefei 258
Helsinki 242
Princeton 232
Boardman 225
Hanoi 199
Los Angeles 188
Chicago 178
Dublin 152
Lauterbourg 150
Council Bluffs 148
Moscow 138
Izmir 136
Sofia 135
Dallas 133
Zgierz 133
Santa Clara 132
Columbus 129
London 120
Frankfurt am Main 96
The Dalles 95
Dearborn 91
New York 85
São Paulo 83
Milan 77
Rome 70
Buffalo 66
Tokyo 66
Casablanca 65
Düsseldorf 55
Orem 52
Brussels 51
Shanghai 46
Dakar 45
San Diego 44
Lappeenranta 43
Dong Ket 42
Redondo Beach 41
Phoenix 38
Nuremberg 37
Vienna 37
Redwood City 36
Turku 36
Falls Church 33
Chennai 32
Manchester 32
Atlanta 31
Amsterdam 30
Denver 30
Guangzhou 30
Montreal 30
Mumbai 30
Da Nang 28
Johannesburg 28
Nanjing 27
Stockholm 27
Haiphong 26
Des Moines 24
Boston 23
Jinan 23
Bremen 22
Brooklyn 22
Curitiba 22
Washington 22
Bologna 21
Rio de Janeiro 21
Wroclaw 21
Belo Horizonte 20
Istanbul 20
Tianjin 20
Toronto 20
Baghdad 19
Pune 19
Tashkent 19
Brno 18
Hangzhou 18
Redmond 18
Shenyang 18
Kunming 17
Sydney 17
Jeddah 16
Mexico City 16
Totale 19.698
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 531
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis 500
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 497
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 461
Role of Oxidative Stress Mediated by Glutathione-S-transferase in Thiopurines' Toxic Effects 450
Pharmacogenetics of thiopurines 447
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 439
Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children 424
Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: Effect of N-acetyl transferase polymorphisms 421
Genetic determinants for methotrexate response in juvenile idiopathic arthritis 410
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 409
Type i interferon-mediated autoinflammation due to DNase II deficiency 388
Patients' Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis? 387
Pharmacogenetics of treatments for inflammatory bowel disease 353
In vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome 314
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 314
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 304
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 298
Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. 282
Cytofluorimetric assay to investigate variability in blinatumomab in vitro response 277
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 270
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 270
Contribution of Glutathione-S-Transferases to the Pharmacogenetics of Azathioprine 264
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 263
Ergothioneine, a dietary amino acid with a high relevance for the interpretation of label-free surface enhanced Raman scattering (SERS) spectra of many biological samples 261
Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives 261
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells 260
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 259
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 257
Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Crohn's disease 255
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients 254
Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease. 252
ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. 248
Targeting kinase-activating genetic lesions to improve therapy of pediatric acute lymphoblastic leukemia 248
Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease 247
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 246
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 245
Novel motif of variable number of tandem repeats in TPMT promoter region and evolutionary association of variable number of tandem repeats with TPMT∗3 alleles 243
Opioid Resistance Associated with CYP3A4 Hyperactivity and COMT Polymorphism in an Oncological Patient 242
Carbamazepine hypersensitivity syndrome triggered by a human herpes virus reactivation in a genetically predisposed patient 241
Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse. 237
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 236
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 229
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 228
Glutathione-S-Transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome 227
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 225
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 224
Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? 223
Pharmacogenomic approaches for tailored anti-leukemic therapy in children. 221
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 216
Understanding thiopurine methyltransferase polymorphisms for the targeted treatment of hematologic malignancies 216
Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease 215
ABCB1 gene polymorphisms and expression of P-glycoprotein and long term prognosis in colorectal cancer 214
SERS of cells: What can we learn from cell lysates? 213
Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. 207
Genetic Predictors of Glucocorticoid Response in Pediatric Patients With Inflammatory Bowel Diseases 205
Effect of periodontal therapy on the course of cyclosporin-induced gingival overgrowth: role of ABCB1 and PAI-1 gene polymorphisms. 203
Prevalence of methylenetetrahydrofolate reductase polymorphisms in young patients with inflammatory bowel disease. 199
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 199
Personalized therapies in pediatric inflammatory and autoimmune diseases. 197
Letter: TPMT activity and age in IBD patients. 196
Usefulness of the measurement of azathioprine metabolites in the assessment of non-adherence 192
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 189
Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia. 188
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias 188
Cancer Pharmacogenomics 185
Distinct effects of dinuclear ruthenium(III) complexes on cell proliferation and on cell cycle regulation in human and murine tumor cell lines. 183
Inflammatory Bowel Disease 178
Thiopurine-S-methyltransferase genotype and the response to azathioprine in inflammatory bowel disease. 178
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 177
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 177
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 175
DMET™ Plus array delivers results in good concordance with those of several lower-throughput genotyping methods in patient samples. 174
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 174
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. 171
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 166
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 166
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 164
Pharmacogenetics, cost of genotyping, and guidelines for individualizing therapy with mercaptopurine in pediatric acute lymphoblastic leukemia. 163
TPMT genotype and the use of thiopurines in pediatric inflammatory bowel disease. 162
Systematic identification of host genomic variation related to treatment outcome of childhood acute lymphoblastic leukemia 161
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile 161
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 161
A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity. 160
Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress 160
Glucocorticoid receptor polymorphisms in inflammatory bowel disease. 158
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 158
Induced pluripotent stem cells as a model for therapy personalizationof pediatric patients: Disease modeling and drug adverse effects prevention 157
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 156
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 156
Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia 155
A new proof of evidence of cysteamine quantification for therapeutic drug monitoring in patients with cystinosis 153
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 152
Processes for incorporation of pharmacogenetic tests and interpretations in medical records for clinical practice. 152
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 150
Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status 150
Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy 149
ITPA genetic polymorphism is possibly associated with survival rate in Korean children with acute lymphoblastic leukemia. 147
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 146
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 146
Totale 23.960
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021543 0 0 0 0 0 0 0 0 0 256 99 188
2021/20221.581 100 110 90 140 40 141 122 55 180 161 95 347
2022/20232.390 237 370 161 347 223 373 22 204 264 49 89 51
2023/20241.698 76 99 64 101 176 144 298 331 30 53 205 121
2024/20254.788 96 257 353 417 390 539 330 341 645 579 379 462
2025/20268.896 995 520 689 872 891 858 1.427 370 1.190 1.084 0 0
Totale 29.555